Institute of Biomedical Research Corp. (MRES)
OTCMKTS · Delayed Price · Currency is USD
0.0012
-0.0002 (-14.29%)
Jun 10, 2026, 3:29 PM EST
MRES Market Cap
MRES has a market cap or net worth of $3.85 million as of June 10, 2026. Its market cap has decreased by -91.09% in one year.
Market Cap
3.85M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 31, 2016, MRES's market cap has increased from 693.95K to 3.85M, an increase of 454.66%. That is a compound annual growth rate of 18.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 3.85M | -50.00% |
| Dec 31, 2025 | 7.70M | -83.96% |
| Dec 31, 2024 | 47.98M | 138.03% |
| Dec 29, 2023 | 20.16M | 17.54% |
| Dec 30, 2022 | 17.15M | 149.69% |
| Dec 31, 2021 | 6.87M | 971.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 6.89M |
| Mosaic ImmunoEngineering | 4.88M |
| Orgenesis | 4.85M |
| Enzolytics | 4.83M |
| GPL Holdings | 4.20M |
| AccuStem Sciences | 4.11M |
| Bioxytran | 3.52M |
| Eastgate Biotech | 3.17M |